相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhaled Microparticles Containing Clofazimine Are Efficacious in Treatment of Experimental Tuberculosis in Mice
Rahul Kumar Verma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Anthelmintic Avermectins Kill Mycobacterium tuberculosis, Including Multidrug-Resistant Clinical Strains
Leah E. Lim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Variations of Subunit ε of the Mycobacterium tuberculosis F1Fo ATP Synthase and a Novel Model for Mechanism of Action of the Tuberculosis Drug TMC207
Goran Biukovic et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
Teesta Dey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test
Stephen D. Lawn et al.
LANCET INFECTIOUS DISEASES (2013)
Tuberculosis biomarkers discovery: developments, needs, and challenges
Robert S. Wallis et al.
LANCET INFECTIOUS DISEASES (2013)
When to Start ART in Africa - An Urgent Research Priority
Kevin M. De Cock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
CURRENT CONCEPTS Tuberculosis
Alimuddin Zumla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Para-Aminosalicylic Acid Acts as an Alternative Substrate of Folate Metabolism in Mycobacterium tuberculosis
Sumit Chakraborty et al.
SCIENCE (2013)
INFECTIOUS DISEASE Approval of Novel TB Drug Celebrated-With Restraint
Jon Cohen
SCIENCE (2013)
Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
Sarah A. Stanley et al.
ACS CHEMICAL BIOLOGY (2012)
MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
Valentina La Rosa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vitro Combination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosis
Benoit Lechartier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
Kapil Tahlan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Structure-Activity Relationships among the Kanamycin Aminoglycosides: Role of Ring I Hydroxyl and Amino Groups
Sumantha Salian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824
Andreas H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Streptomycin-Starved Mycobacterium tuberculosis 18b, a Drug Discovery Tool for Latent Tuberculosis
Ming Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
David M. Tobin et al.
CELL (2012)
Totally Drug-Resistant Tuberculosis in India
Zarir F. Udwadia et al.
CLINICAL INFECTIOUS DISEASES (2012)
Old Drugs, New Purpose: Retooling Existing Drugs for Optimized Treatment of Resistant Tuberculosis
Kelly E. Dooley et al.
CLINICAL INFECTIOUS DISEASES (2012)
Modelling tuberculosis trends in the USA
A. N. Hill et al.
EPIDEMIOLOGY AND INFECTION (2012)
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Alena Skrahina et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
Giovanni Sotgiu et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis
Frederick A. Sirgel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of Mycobacterium tuberculosis in Human Macrophages
Heiko Bruns et al.
JOURNAL OF IMMUNOLOGY (2012)
Adjunct Immunotherapies for Tuberculosis
Michael Uhlin et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities
Ruth McNerney et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Innovative Trial Designs Are Practical Solutions for Improving the Treatment of Tuberculosis
Patrick P. J. Phillips et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-D-ribofuranose 2′-Oxidase DprE1
Claudia Trefzer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
Andreas H. Diacon et al.
LANCET (2012)
Scaling up interventions to achieve global tuberculosis control: progress and new developments
Mario Raviglione et al.
LANCET (2012)
Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosis
Pradeep Kumar et al.
MOLECULAR MICROBIOLOGY (2012)
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
Anna E. Grzegorzewicz et al.
NATURE CHEMICAL BIOLOGY (2012)
Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis
Frederick A. Sirgel et al.
MICROBIAL DRUG RESISTANCE (2012)
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Maria Tarcela Gler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Myungsun Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model
Mamoudou Maiga et al.
PLOS ONE (2012)
Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide
Robert S. Wallis et al.
PLOS ONE (2012)
Adjunctive TNF Inhibition with Standard Treatment Enhances Bacterial Clearance in a Murine Model of Necrotic TB Granulomas
Ciaran Skerry et al.
PLOS ONE (2012)
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques
Philana Ling Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors
Sarah M. Batt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis
Joao Neres et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project
Corinne S. C. Merle et al.
TRIALS (2012)
Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap
Payam Nahid et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Structure of the Mycobacterium tuberculosis D-Alanine:D-Alanine Ligase, a Target of the Antituberculosis Drug D-Cycloserine
John B. Bruning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis
Robert S. Wallis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
Kristin N. Adams et al.
CELL (2011)
Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
Ruth J. Napier et al.
CELL HOST & MICROBE (2011)
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
Jakko van Ingen et al.
CLINICAL INFECTIOUS DISEASES (2011)
New tuberculosis drugs on the horizon
Stewart T. Cole et al.
CURRENT OPINION IN MICROBIOLOGY (2011)
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D. Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Initiating antiretrovirals during tuberculosis treatment: a drug safety review
Tanuja N. Gengiah et al.
EXPERT OPINION ON DRUG SAFETY (2011)
Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients
A. H. Diacon et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2011)
Efficacy and Safety of a 4-Drug Fixed-Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary Tuberculosis The Study C Randomized Controlled Trial
Christian Lienhardt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The challenge of new drug discovery for tuberculosis
Anil Koul et al.
NATURE (2011)
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Timothy R. Sterling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis
Francois-Xavier Blanc et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Diane V. Havlir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MEROPENEM/CLAVULANATE AND LINEZOLID TREATMENT FOR EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Nicolas Dauby et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Wanliang Shi et al.
SCIENCE (2011)
Phosphodiesterase-4 Inhibition Alters Gene Expression and Improves Isoniazid - Mediated Clearance of Mycobacterium tuberculosis in Rabbit Lungs
Selvakumar Subbian et al.
PLOS PATHOGENS (2011)
Immunological biomarkers of tuberculosis
Gerhard Walzl et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Armand Van Deun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor
E. Huitric et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals Are Uniformly Susceptible to Benzothiazinones
Maria Rosalia Pasca et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207
Venkata M. Reddy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Treatment Outcomes among Patients with Extensively Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis
Karen R. Jacobson et al.
CLINICAL INFECTIOUS DISEASES (2010)
Pharmacokinetics and Whole-Blood Bactericidal Activity against Mycobacterium tuberculosis of Single Doses of PNU-100480 in Healthy Volunteers
Robert S. Wallis et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β-D-ribose 2′-epimerase DprE1 of Mycobacterium tuberculosis
Claudia Trefzer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Global tuberculosis drug development pipeline: the need and the reality
Zhenkun Ma et al.
LANCET (2010)
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study
Keertan Dheda et al.
LANCET (2010)
Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis
David J. Horne et al.
LANCET INFECTIOUS DISEASES (2010)
Leads for antitubercular compounds from kinase inhibitor library screens
Sophie Magnet et al.
TUBERCULOSIS (2010)
A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis
Nicolas Veziris et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Shortening Treatment in Adults with Noncavitary Tuberculosis and 2-Month Culture Conversion
John L. Johnson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic Homologue
Anna C. Haagsma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov et al.
SCIENCE (2009)
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
Jean-Emmanuel Hugonnet et al.
SCIENCE (2009)
High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
Thierry Christophe et al.
PLOS PATHOGENS (2009)
A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents
Julian G. Hurdle et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis
Anil Koul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prevention of drug carryover effects in studies assessing antimycobacterial efficacy of TMC207
Nacer Lounis et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
Srinivasa P. S. Rao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Ramandeep Singh et al.
SCIENCE (2008)
The early bactericidal activity of anti-tuberculosis drugs: a literature review
P. R. Donald et al.
TUBERCULOSIS (2008)
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model
Ian M. Rosenthal et al.
PLOS MEDICINE (2007)
Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1
Coenraad Kuijl et al.
NATURE (2007)
Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears
A. H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Diarylquinolines target subunit c of mycobacterial ATP synthase
Anil Koul et al.
NATURE CHEMICAL BIOLOGY (2007)
Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps
Leonard Amaral et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
Neel R. Gandhi et al.
LANCET (2006)
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice
Makoto Matsumoto et al.
PLOS MEDICINE (2006)
Mycobacterium leprae is naturally resistant to PA-824
Ujjini H. Manjunatha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis
UH Manjunatha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Linezolid for the treatment of multidrug-resistant tuberculosis
J Fortún et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
K Andries et al.
SCIENCE (2005)
Tuberculosis - Metabolism and respiration in the absence of growth
HIM Boshoff et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis
EL Nuermberger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days
A Jindani et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates
RE Lee et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2003)
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
CK Stover et al.
NATURE (2000)
分享论文
